SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nephrocare Health Services gets SEBI’s nod for IPO

11 Nov 2025 Evaluate

Dialysis services provider Nephrocare Health Services, known for its brand NephroPlus, has secured Securities and Exchange Board of India’s (SEBI's) approval to raise funds through initial public offering (IPO). The IPO of the company involves a fresh issue of equity shares valued at Rs 353.4 crore and an OFS of 1.27 crore shares by promoters and existing shareholders. 

The company proposes to utilise proceeds of the fresh issue to the tune of Rs 129.1 crore for opening new dialysis clinics in India, Rs 136 crore for payment of debt and the rest on general corporate purposes.

NephroPlus, incorporated in 2009, recently announced crossing 500 dialysis centres globally. It has operations across four countries -- India, the Philippines, Uzbekistan, and Nepal, serving over 33,000 patients annually. 


About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×